125 related articles for article (PubMed ID: 23290441)
1. The impact of preradiation residual disease volume on time to locoregional failure in cutaneous Merkel cell carcinoma--a TROG substudy.
Finnigan R; Hruby G; Wratten C; Keller J; Tripcony L; Dickie G; Rischin D; Poulsen M
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):91-5. PubMed ID: 23290441
[TBL] [Abstract][Full Text] [Related]
2. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
Poulsen MG; Rischin D; Porter I; Walpole E; Harvey J; Hamilton C; Keller J; Tripcony L
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):114-9. PubMed ID: 16125873
[TBL] [Abstract][Full Text] [Related]
3. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.
Poulsen M; Rischin D; Walpole E; Harvey J; Mackintosh J; Ainslie J; Hamilton C; Keller J; Tripcony L;
J Clin Oncol; 2003 Dec; 21(23):4371-6. PubMed ID: 14645427
[TBL] [Abstract][Full Text] [Related]
4. Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin.
Foote M; Harvey J; Porceddu S; Dickie G; Hewitt S; Colquist S; Zarate D; Poulsen M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):677-84. PubMed ID: 19906498
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.
Howle JR; Hughes TM; Gebski V; Veness MJ
J Am Acad Dermatol; 2012 Jul; 67(1):33-40. PubMed ID: 21996296
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy compliance in high-risk Merkel cell carcinoma treated with chemoradiotherapy.
Gorayski P; Tripcony L; Poulsen M
Australas J Dermatol; 2017 Feb; 58(1):35-41. PubMed ID: 26627052
[TBL] [Abstract][Full Text] [Related]
7. Natural history of merkel cell carcinoma following locoregional recurrence.
Grotz TE; Tarantola TI; Otley CC; Weaver AL; McGree ME; Jakub JW
Ann Surg Oncol; 2012 Aug; 19(8):2556-62. PubMed ID: 22453243
[TBL] [Abstract][Full Text] [Related]
8. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
Foote M; Veness M; Zarate D; Poulsen M
J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
10. Five hundred patients with Merkel cell carcinoma evaluated at a single institution.
Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Allen PJ; Kraus DH; Brady MS; Coit DG
Ann Surg; 2011 Sep; 254(3):465-73; discussion 473-5. PubMed ID: 21865945
[TBL] [Abstract][Full Text] [Related]
11. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma: prognosis and treatment of patients from a single institution.
Allen PJ; Bowne WB; Jaques DP; Brennan MF; Busam K; Coit DG
J Clin Oncol; 2005 Apr; 23(10):2300-9. PubMed ID: 15800320
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer.
Han TJ; Kim HJ; Wu HG; Heo DS; Kim YW; Lee SH
Jpn J Clin Oncol; 2012 Oct; 42(10):948-54. PubMed ID: 22811409
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant local irradiation for Merkel cell carcinoma.
Lewis KG; Weinstock MA; Weaver AL; Otley CC
Arch Dermatol; 2006 Jun; 142(6):693-700. PubMed ID: 16785371
[TBL] [Abstract][Full Text] [Related]
16. Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
Reymen B; Van Loon J; van Baardwijk A; Wanders R; Borger J; Dingemans AM; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1319-24. PubMed ID: 23200174
[TBL] [Abstract][Full Text] [Related]
17. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
Kim JY; Kim JY; Kim JH; Yoon MS; Kim J; Kim YS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):741-7. PubMed ID: 22898382
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.
Fields RC; Busam KJ; Chou JF; Panageas KS; Pulitzer MP; Allen PJ; Kraus DH; Brady MS; Coit DG
Cancer; 2012 Jul; 118(13):3311-20. PubMed ID: 22072529
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
